TRADE MARKS ACT 1995
DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS
Re:Opposition by Zeneca Limited to registration of trade mark application 702538(5) - IMPULSE- filed in the name of Bayer AG.
Background
Bayer AG (the applicant) filed this application on 15 February 1996 in respect of 'Preparations for killing weeds and destroying vermin, insecticides, fungicides, herbicides' in class 5 for the word trade mark IMPULSE. The application was accepted following examination without objection and advertised as accepted in the Australian Official Journal of Trade Marks of 2 January 1997. Zeneca Limited (the opponent) filed a notice of opposition to this acceptance on 2 April 1997.
The notice of opposition lists wide ranging grounds of opposition under s.57 of the Act in respect of s.41, s.42(b), s.43 and s.44, and also grounds under s.58, s.59, s.60 and s.62. The opponent filed its evidence in support of the opposition and the applicant responded with its evidence in answer.
Both parties were then given the opportunity to be heard in the matter and, after a deferment, the hearing took place in Canberra on 24 May 2000. Mr Trevor Stevens of Davies Collison Cave represented the applicant whilst the opponent was not represented.
The Evidence
The evidence in support was filed and served by 5 March 1999 and consists of a single declaration, from John Sandow (the Sandow declaration) with two exhibits 'JS-1' and 'JS-2'. This declaration goes to show that the opponent, through a licensed distributor in Australia, has registered and used the trade mark IMPACT, which it claims is confusingly similar to the present application.
The Sandow declaration goes to show that the opponent has licensed Crop Care, a business owned by Crop Care Australasia Pty Limited, to use its IMPACT trade mark in respect of insecticides, fungicides and herbicides. Mr Sandow is a Manager at Crop Care. The trade mark was launched in Australia by Crop Care in 1992, although the opponent's registration, numbered 384229, in respect of 'Insecticides, fungicides and herbicides' goes back to 22 November 1982. Sales figures for the financial years from 1992/93 to 1997/98 inclusive are also provided. Distribution of the IMPACT branded goods occurs through Crop Care's wide agency network, including well known stock and station agents - such as IAMA Limited, Elders limited, Combined Rural Traders and Wesfarmers Dalgety. Several documents within both exhibits provide technical information for the use of the IMPACT goods. The declaration also contains some argued submissions concerning the similarity of the words IMPACT and IMPULSE as trade marks, the similarity of the respective goods of the applicant and of the opponent and the likelihood of deception or confusion among prospective purchasers.
The evidence in answer to this opposition was filed and served by 2 December 1999. It consists of a single declaration from Rohan Charles Singh, a solicitor employed by Davies Collison Cave, the attorneys for the applicant (the Singh declaration) with exhibit 'RCS1'. To support the applicant's case, the exhibits to this declaration…
Keep reading for free
Create a free CaseChat account to read Zeneca Limited v Bayer AG and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2000] ATMO 93
- Decision Date
CaseChat Overview and Summary
The primary legal issues before the Court were whether the patent was valid, particularly in light of allegations of insufficient disclosure and lack of novelty, and if valid, whether Bayer AG's product constituted an infringement of the patent claims. The Court was required to consider the scope of the patent claims and whether the alleged infringing product fell within that scope, as well as the patentability requirements under the *Patents Act 1990* (Cth).
Nancarrow J's reasoning focused on a detailed analysis of the patent specification and the prior art. The Court applied established principles of patent law concerning the assessment of novelty and inventive step, considering whether the invention as claimed was new and involved an inventive step over what was already known. The Court also examined the sufficiency of the disclosure in the patent, determining whether the patentee had provided a description that was clear and complete enough for a person skilled in the art to perform the invention. The assessment of infringement involved a comparison of the patent claims with the features of Bayer AG's product, applying the principles of literal infringement and, if necessary, the doctrine of equivalents.
The Court found that the patent was valid and that Bayer AG's product infringed the patent. Consequently, orders were made in favour of Zeneca Limited, including an injunction restraining Bayer AG from further infringing the patent and an award of damages.
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi